Ruling Upheld In Appetite Stimulant Patent Feud

Law360, New York (October 26, 2007, 12:00 AM EDT) -- In a boost to Roxane Laboratories Inc., an appeals court has affirmed a lower court’s grant of summary judgment of invalidity of the asserted claims of two patents held by Par Pharmaceuticals Inc. covering an appetite stimulant product.

In a decision handed down Friday in the U.S. Court of Appeals for the Federal Circuit, a three-judge panel said that the U.S. District Court for the District of New Jersey properly determined that the asserted claims of the patents were invalid as a matter of law for...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.